Dipentum and Joint pain - a phase IV clinical study of FDA data

Summary:

Joint pain is reported as a side effect among people who take Dipentum (olsalazine sodium), especially for people who are female, 60+ old, also take Remicade, and have Osteoporosis.

The phase IV clinical study analyzes which people have Joint pain when taking Dipentum. It is created by eHealthMe based on reports of 345 people who have side effects when taking Dipentum from the FDA, and is updated regularly.

What is Dipentum?

Dipentum has active ingredients of olsalazine sodium. It is often used in ulcerative colitis. eHealthMe is studying from 358 Dipentum users. Check the latest studies of Dipentum.

What is Joint pain?

Joint pain is found to be associated with 3,331 drugs and 5,207 conditions by eHealthMe. Check the latest studies of Joint pain.

On Jul, 20, 2026

345 people reported to have side effects when taking Dipentum.
Among them, 18 people (5.22%) have Joint pain.

Among these 18 people:

What is the gender of people who have Joint pain when taking Dipentum? *

female: 61.11 %
male: 38.89 %

What is the age of people who have Joint pain when taking Dipentum? *

What are other drugs people take besides Dipentum? *

What are other side effects people have besides Joint pain? *

Muscle Aches (muscle pain): 7 people, 38.89%
Pain In Extremity: 7 people, 38.89%
Back Pain: 6 people, 33.33%
Fatigue (feeling of tiredness): 5 people, 27.78%
Foot Fracture: 4 people, 22.22%
Inflammatory Bowel Disease: 4 people, 22.22%
Insomnia (sleeplessness): 4 people, 22.22%
Cyst (a closed sac): 4 people, 22.22%
Depression: 4 people, 22.22%
Fall: 4 people, 22.22%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 6 people, 33.33%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.56%
Pain: 1 person, 5.56%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 5.56%
Nausea (feeling of having an urge to vomit): 1 person, 5.56%
Liver Disorder (liver diseases): 1 person, 5.56%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.56%
Gastric Disorder (disease of stomach): 1 person, 5.56%
Fluid Imbalance (imbalance of fluid in body in intake and fluid lost): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Dipentum and have Joint pain?

- Check whether Joint pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dipentum:

Dipentum (358 reports)

Joint pain treatments and more:

Joint pain (542,934 reports)

Browse all side effects of Dipentum:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint pain:

Joint pain (3,331 drugs)

Browse all the conditions that are associated with Joint pain:

Joint pain (5,207 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on olsalazine sodium (the active ingredients of Dipentum) and Dipentum (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.